Horizon Discovery Group has appointed Terry Pizzie as CEO and board member, effective immediately. Pizzie joined Horizon in 2017 as head of commercial operations and has nearly 30 years of experience in the biotechnology tools sector. Prior to joining Horizon, Pizzie worked for Pacific Biosciences, first as a vice president in Europe, and later as head of global sales. His previous leadership roles include director of global commercial operations at Genetix prior to its acquisition by Danaher, and senior vice president of global commercial operations at Swedish biotech firm Biacore. He started his career at Applied Biosystems in 1988.